AzTrials
AzTrials

Morbid ObesityNCT04932642

Nonresponders by the Session Order Factor

A study testing HIIT+RT experimental group and RT+HIIT experimental group in people with Morbid Obesity and Sports Physical Therapy, run by Cristian Alvarez at 1 site in Chile.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Concurrent training (CT, characterised by the inclusion of two exercise modalities), is recognised to improve metabolic syndrome (MetS) markers, but little is known about order session effect on interindividual variability. Read more about this study

Who is it for?
Ages 18 to 60 years
Conditions the study is for
Morbid Obesity, Sports Physical Therapy
What is being tested?
HIIT+RT experimental group and RT+HIIT experimental group
Could I receive a placebo?
No, everyone receives an active treatment
How many people
43 participants
Where
1 siteChile
Study dates
1 Mar 2019to 6 Jul 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • being a candidate for bariatric surgery
  • aged between 18 and 60 years
  • tobe medically authorised
  • with a body mass index (BMI) ≥40 kg/m2 or ≥35 kg/m2
  • with additional comorbidities (i.e. diabetes, hypertension, insulin resistance) controlled by pharmacotherapy

Who cannot join

  • having physical limitations preventing the performance of exercise (e.g. restricting injuries of the musculoskeletal system)
  • having exercise-related dyspnoea or respiratory alterations
  • having chronic heart disease with any worsening in the last month
  • adhering to less than 80% of the total interventions (these results were excluded from the statistical analyses)

Trial locations and contacts

1 site in 1 country.

Chile1 site
  • Cristian ALvarez

    Osorno, Llanquihue, 5290000

Other trials in Chile

About this study

Official title: The Effects of Two Different Orders of Concurrent Training on the Interindividual Variability of Health Markers of Metabolic Syndrome and Fitness in Severe/Morbidly Obesity Women. A Randomized Control Trial

Concurrent training (CT, characterised by the inclusion of two exercise modalities), is recognised to improve metabolic syndrome (MetS) markers, but little is known about order session effect on interindividual variability. The purpose of the present study was to describe the effects, and the interindividual variability, of 20 weeks of CT in different order at (i.e., high intensity interval training (HIIT) plus resistance training (RT), compared with another group doing RT plus HIIT) in women with severe/morbidly obesity at risk of MetS.

Read the detailed description

Morbid obesity, defined as a body mass index (BMI) of 40 kg/m2 (class III obesity), is a chronic disease with life-threatening cardiometabolic consequences such as elevated blood pressure (systolic [SBP] or diastolic BP [DBP]), fasting plasma glucose (FPG), triglycerides (Tg), and low high-density lipoprotein cholesterol (HDL-c), all summarised as metabolic syndrome (MetS). In this sense, exercise training as resistance training (RT), defined as any exercise that causes voluntary skeletal muscle contraction by using external weights such as dumbbells and metal bars, is a known non-pharmacotherapy strategy for improving muscle strength and functional capacity in obese patients undergoing bariatric surgery. Similarly, high-intensity interval training (HIIT), defined as several and brief bouts of high-intensity effort usually by cycling/running, interspersed by recovery periods ), has produced strong evidence for the improvement of cardiometabolic risk factors for type 2 diabetes mellitus, arterial hypertension, central arterial stiffness and, vascular function, and cardiorespiratory fitness. Thus, in individuals with morbid obesity, for example, exercise training has proven to be effective for inducing clinically significant weight loss (5-10%), and for the reduction of cardiovascular risk, following the standard recommendations for these cohorts prior to bariatric surgical. However, some inconsistencies have been described after CT, which are directly concerned with the 'order' (i.e. starting the CT session with MICT followed by RT, or vice versa) of the CT session. However, little is known about the interindividual variability of exercise training (IVET) in relation to different order sessions of CT in morbidly obese populations and health-related outcomes, such as MetS markers. Briefly, IVET means that some subjects achieve benefits after training, and are termed responders (Rs), while others exhibit a worsened or unchanged response, and that is commonly known termed as nonresponders (NRs).

Being tested
HIIT+RT experimental group, RT+HIIT experimental group
Keywords
Morbid obesity, Exercise training, Metabolic syndrome, Concurrent training, Exercise order
Medical subject headings
Obesity, Morbid, Metabolic Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HIIT+RT experimental groupBehavioural

    Each experimental group will be compared with their another contrast order session group

  • RT+HIIT experimental groupBehavioural

    Each experimental group will be compared with their another contrast order session group

Study groups in NCT04932642
Study groupRoleWhat they receive
High-intensity interval training plus resistance training (HIIT+RT)ExperimentalThe HIIT+RT group, the HIIT section consisted of 60 seconds of maximum intensity exercise using a magnetic resistance static bicycle (OxfordTM Fitness, model BE-2701, Chile), followed by 60-120 seconds of passive recovery over the bicycle totally off. This was repeated four to seven times according to the weekly schedule. The intensity of the exercise was measured on the Borg scale of 1 to 10 of perceived exertion and the participants worked at a level of between 6 to 9 points. Second, in the RT section, three to out of four RT exercises were included (according to the planning week), targeting the following different muscle groups: (1) forearm, (2) knee flexors and extensors, (3) trunk, (4) chest, (5) shoulder elevators, (6) horizontal shoulder flexors, (7) extensors, and finally (8) plantar flexors. These exercises were performed in three 3 sets of as many repetitions as possible in 60 seconds, followed by 60 to 120 seconds of passive recovery.
Receives: Behavioral: HIIT+RT experimental group
Resistance training plus High-intensity interval training (RT+HIIT)ExperimentalFirstly, in the RT section, three to out of four RT exercises were included (according to the planning week), targeting the following different muscle groups: (1) forearm, (2) knee flexors and extensors, (3) trunk, (4) chest, (5) shoulder elevators, (6) horizontal shoulder flexors, (7) extensors, and finally (8) plantar flexors. These exercises were performed in three 3 sets of 60 seconds, followed by 60 to 120 seconds of passive recovery, as previously reported. Secondly, in the HIIT+RT group, the HIIT section consisted of 60 seconds of maximum intensity exercise using a magnetic resistance static bicycle (OxfordTM Fitness, model BE-2701, Chile), followed by 60-120 seconds of passive recovery over the bicycle totally off. This was repeated four to seven times according to the weekly schedule. The intensity of the exercise was measured on the Borg scale of 1 to 10 of perceived exertion and the participants worked at a level of between 6 to 9 points.
Receives: Behavioral: RT+HIIT experimental group

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Fasting glucose

    Component of metabolic syndrome risk factors

    Measured: Baseline to 20-weeks of concurrent training

  2. Waist circumference

    Component of metabolic syndrome risk factors

    Measured: Baseline to 20-weeks of concurrent training

  3. Systolic blood pressure

    Component of metabolic syndrome risk factors

    Measured: Component of metabolic syndrome risk factors

  4. Diastolic blood pressure

    Component of metabolic syndrome risk factors

    Measured: Baseline to 20-weeks of concurrent training

  5. High-density lipoprotein cholesterol

    Component of metabolic syndrome risk factors

    Measured: Baseline to 20-weeks of concurrent training

  6. Triglycerides

    Component of metabolic syndrome risk factors

    Measured: Baseline to 20-weeks of concurrent training

Secondary outcomes (10)
  1. Body mass (kg)

    Anthropometry parameter related with health and intervention effects. This outcome will be measured by a bio-impedance scale (TANITATM, model 331, Tokyo, Japan).

    Measured: Baseline to 20-weeks of concurrent training

  2. Body mass index (height/m2)

    Anthropometry parameter related with health and intervention effects

    Measured: Baseline to 20-weeks of concurrent training

  3. Body fat percentage (%)

    Anthropometry parameter related with health and intervention effects

    Measured: Baseline to 20-weeks of concurrent training

  4. Body fat (kilograms)

    Anthropometry parameter related with health and intervention effects

    Measured: Baseline to 20-weeks of concurrent training

  5. Skeletal muscle mass (kg)

    Body composition parameter related with health and intervention effects. This outcome will be measured by a bio-impedance scale (TANITATM, model 331, Tokyo, Japan).

    Measured: Baseline to 20-weeks of concurrent training

  6. Lean mass (kg)

    Body composition parameter related with health and intervention effects. This outcome will be measured by a bio-impedance scale (TANITATM, model 331, Tokyo, Japan).

    Measured: Baseline to 20-weeks of concurrent training

  7. Total cholesterol

    Metabolic parameter related with health and intervention effects

    Measured: Baseline to 20-weeks of concurrent training

  8. Low-density lipoprotein cholesterol

    Metabolic parameter related with health and intervention effects

    Measured: Baseline to 20-weeks of concurrent training

  9. Handgrip muscle strength (kg)

    Physical fitness outcome related with health and intervention effects. This outcome will be measure using a digital dynamometer (BaselineTM Hydraulic Hand Dynamometers, USA),

    Measured: Baseline to 20-weeks of concurrent training

  10. Six minutes walking test

    Physical fitness outcome related with health and intervention effects

    Measured: Baseline to 20-weeks of concurrent training

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Jun 2021
  2. Study start1 Mar 2019
  3. Primary completion31 Dec 2019
  4. Study completion6 Jul 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Model description
We will compare a concurrent training group (HIIT+RT) with morbid obesity with another experimental group of concurrent training with morbid obesity, but with another exercise order (RT+HIIT).
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
43 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04932642
Sponsor's protocol ID
RP08042020
Status last verified
Jun 2021
First submitted
2 Jun 2021
Last updated
21 Jun 2021
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: The participant's information will be available by e-mail according to with researcher's requirements.

Questions about this trial

What is this clinical trial studying?

A study testing HIIT+RT experimental group and RT+HIIT experimental group in people with Morbid Obesity and Sports Physical Therapy, run by Cristian Alvarez at 1 site in Chile.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Jun 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Chile. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Fasting glucose (time frame: Baseline to 20-weeks of concurrent training). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Jun 2021.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in